Filing Details

Accession Number:
0000059478-17-000019
Form Type:
5
Zero Holdings:
No
Publication Time:
2017-01-27 12:21:01
Reporting Period:
2016-12-31
Filing Date:
2017-01-27
Accepted Time:
2017-01-27 12:21:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1524637 M Fionnuala Walsh Lilly Corporate Center
Indianapolis IN 46285
Svp, Global Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-16 3,000 $72.23 55,618 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,041 Indirect 401(k)
Common Stock 31,651 Indirect by husband
Common Stock 1,127 Indirect 401(k) - by husband
Footnotes
  1. Reporting person disclaims beneficial ownership of these shares.